ABL Bio Inc (298380) — Financial Flexibility Index
ABL Bio Inc (298380) has a Financial Flexibility Index of -0.17x as of December 2025. Free cash flow of ₩-20.85 Billion (operating CF ₩-23.62 Billion minus capex ₩2.78 Billion) represents 0% of total liabilities (₩124.24 Billion). Also explore net asset momentum of ABL Bio Inc to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
ABL Bio Inc Financial Flexibility Index (2016–2025)
Historical Financial Flexibility Index trend for ABL Bio Inc across 10 annual periods. Check ABL Bio Inc PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for ABL Bio Inc (2016–2025)
Year-by-year free cash flow to debt coverage for ABL Bio Inc. For the full company profile including market capitalisation, see 298380 stock market capitalisation.
| Year | Flexibility Index | Free Cash Flow (KRW) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.17x | ₩-20.58 Billion | ₩-41.25 Billion | ₩124.24 Billion | ▲ +82.2% |
| 2024 | -0.93x | ₩-60.34 Billion | ₩-69.40 Billion | ₩64.70 Billion | ▼ -256.5% |
| 2023 | -0.26x | ₩-22.52 Billion | ₩-28.36 Billion | ₩86.07 Billion | ▼ -140.8% |
| 2022 | 0.64x | ₩74.19 Billion | ₩72.13 Billion | ₩115.67 Billion | ▲ +115.5% |
| 2021 | -4.14x | ₩-39.36 Billion | ₩-40.61 Billion | ₩9.50 Billion | ▲ +18.4% |
| 2020 | -5.08x | ₩-46.86 Billion | ₩-47.29 Billion | ₩9.23 Billion | ▼ -148.4% |
| 2019 | -2.04x | ₩-22.26 Billion | ₩-23.86 Billion | ₩10.89 Billion | ▼ -111.3% |
| 2018 | -0.97x | ₩-11.52 Billion | ₩-12.67 Billion | ₩11.91 Billion | ▼ -1522.3% |
| 2017 | -0.06x | ₩-6.34 Billion | ₩-7.14 Billion | ₩106.32 Billion | ▼ -18.7% |
| 2016 | -0.05x | ₩-985.97 Million | ₩-3.12 Billion | ₩19.63 Billion | — |